ROFLUMILAST- roflumilast tablet 
Micro Labs Limited

----------

MEDICATION GUIDE

Roflumilast (roe-FLUE-mi-last) Tablets


Read this Medication Guide before you start taking roflumilast tablets and each time you get a refill. There may be new information. This information does not take the place of talking with your healthcare provider about your medical condition or treatment.


What is the most important information I should know about roflumilast tablets?


Roflumilast tablets can cause serious side effects. Tell your healthcare provider right away if you have any of the symptoms listed below while taking roflumilast tablets.


1.  Roflumilast tablets may cause mental health problems including suicidal thoughts and behavior. Some people taking roflumilast tablets may develop mood or behavior problems including:



2.  Weight loss. Roflumilast tablets can cause weight loss. You should check your weight on a regular basis. You will also need to see your healthcare provider regularly to have your weight checked. If you notice that you are losing weight, call your healthcare provider. Your healthcare provider may ask you to stop taking roflumilast tablets if you lose too much weight.


Roflumilast tablets may affect the way other medicines work, and other medicines may affect how roflumilast tablets works. Tell your healthcare provider about all the medicines you take, including prescription and non-prescription medicines, vitamins, and herbal supplements.


What are roflumilast tablets?


Roflumilast tablets are a prescription medicine used in adults with severe Chronic Obstructive Pulmonary Disease (COPD) to decrease the number of flare-ups or the worsening of COPD symptoms (exacerbations).


Roflumilast tablets are not a bronchodilator and should not be used for treating sudden breathing problems. Your healthcare provider may give you other medicine to use for sudden breathing problems.

It is not known if roflumilast tablets are safe and effective in children.


Who should not take roflumilast tablets?

Do not take roflumilast tablet if you:


 

What should I tell my healthcare provider before taking roflumilast tablets?


Before you take roflumilast tablets, tell your healthcare provider if you:


 

How should I take roflumilast tablets?


 

What are the possible side effects of roflumilast tablets?

Roflumilast tablets can cause serious side effects, including:


See “ What is the most important information I should know about roflumilast tablets?


The most common side effects of roflumilast tablets include:



Tell your healthcare provider if you have any side effect that bothers you or that does not go away.


These are not all the possible side effects of roflumilast tablets.


Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


How do I store roflumilast tablets?

 

 

Keep roflumilast tablets and all medicines out of the reach of children.

 

General information about roflumilast tablets


Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use roflumilast tablets for a condition for which it was not prescribed. Do not give roflumilast tablets to other people, even if they have the same symptoms that you have. It may harm them.


This Medication Guide summarizes the most important information about roflumilast tablets. For more information about roflumilast tablets, talk with your healthcare provider. You can ask your healthcare provider or pharmacist for information about roflumilast tablets that is written for health professionals.


For more information about roflumilast tablets call 1-855-839-8195.

 

What are the ingredients in roflumilast tablets?

 

Active ingredient: roflumilast

Inactive ingredients: hydroxypropyl cellulose, lactose monohydrate, magnesium stearate, and maize starch.


This Medication Guide has been approved by the U.S. Food and Drug Administration.


Manufactured by:
Micro Labs Limited
Goa-403 722, INDIA.


Manufactured for:
Micro Labs USA, Inc.
Somerset, NJ 08873


Revised: 02/2023

Revised: 4/2023
Micro Labs Limited